Akari Therapeutics Plc (AKTX)

8.72 -0.12 (-1.36%) USD  |  NASDAQ  |  Oct 02, 16:00
8.07 -0.65 (-7.45%) After-Hours: 04:52
More

Akari Therapeutics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to . Start Trial.
Date Value

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
DBV Technologies SA --
Cellectis SA Upgrade
Bicycle Therapeutics Plc Upgrade
Autolus Therapeutics Plc Upgrade
Evaxion AS Upgrade